Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
1.
J Hosp Infect ; 131: 12-22, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36183929

ABSTRACT

BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants. AIM: To evaluate the virucidal efficacy of 72 commercially available disinfectants constituting 16 types of ingredients against SARS-CoV-2. METHODS: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3-5 days of SARS-CoV-2 infection. FINDINGS: This study found that disinfectants based on 83% ethanol, 60% propanol/ethanol, 0.00108-0.0011% sodium dichloroisocyanurate and 0.497% potassium peroxymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05-0.4% benzalkonium chloride (BAC), 0.02-0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205-0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04-4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205-0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2. CONCLUSION: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concentration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid.


Subject(s)
COVID-19 , Disinfectants , Humans , Disinfectants/pharmacology , SARS-CoV-2 , COVID-19/prevention & control , Peracetic Acid , Benzalkonium Compounds , Ethanol
2.
Diabet Med ; 36(10): 1312-1318, 2019 10.
Article in English | MEDLINE | ID: mdl-31254366

ABSTRACT

AIM: Few data are available on the gender-related differences in the prognostic impact of diabetes in people with heart failure. This study was performed to investigate whether there is a gender difference in the association between diabetes and long-term clinical outcomes in people hospitalized for heart failure. METHODS: A total of 3162 people hospitalized with heart failure (aged 67.4 ± 14.1 years, 50.4% females) from the data set of the nationwide registry were analysed. The primary endpoint was a composite of all-cause mortality and heart failure readmission. RESULTS: People with diabetes (30.5% for males vs. 31.1% for females, P = 0.740) were older and had more unfavourable risk factors and laboratory findings than those without diabetes in both genders. During a median follow-up period of 549 days, there were 1418 cases of composite events (44.8%). In univariable analysis, the coexistence of diabetes was significantly associated with a higher incidence of composite events in both genders (P < 0.05 each for males and females). In multivariable analysis, the prognostic impact of diabetes on the development of composite events remained significant in females even after controlling for potential confounders (hazard ratio 1.43, 95% confidence intervals 1.12-1.84; P = 0.004). However, an independent association between diabetes and composite events was not seen in males in the same multivariable analysis (P > 0.05). CONCLUSIONS: In people with heart failure, the impact of diabetes on long-term mortality and heart failure readmission seems to be stronger in females than in males. More careful and intensive management is needed especially in females with heart failure and diabetes.


Subject(s)
Diabetes Mellitus/epidemiology , Heart Failure/epidemiology , Sex Factors , Aged , Aged, 80 and over , Comorbidity , Diabetes Mellitus/mortality , Female , Heart Failure/mortality , Hospitalization , Humans , Male , Middle Aged , Patient Readmission , Prognosis , Registries , Republic of Korea/epidemiology , Risk Factors
3.
Oper Dent ; 44(4): 405-413, 2019.
Article in English | MEDLINE | ID: mdl-30629466

ABSTRACT

This in vitro study examined the utility of comparing red fluorescence between active and inactive caries lesions and investigated whether changes in red fluorescence and fluorescence loss are influenced by lesion activity following remineralization. Sixty-two noncavitated smooth surface caries lesions on extracted human teeth were classified into active or inactive lesions using the Nyvad system prior to a 12-day pH-cycling procedure. Quantitative light-induced fluorescence-digital images were used to measure fluorescence parameters before and after pH cycling. At baseline, the intensity (ΔR) and area (AΔR) of red fluorescence were 1.5- and 2.2-fold higher in active lesions than in inactive lesions (p<0.05). The ratio of AΔR to lesion area was associated with classification of active lesions (odds ratio = 1.031; 95% confidence interval = 1.005-1.058). After pH cycling, the active lesions showed about 2- and 8-fold greater reductions in the median values of AΔR and fluorescence loss related to lesion volume (ΔQ) compared with inactive lesions (p<0.05). In conclusion, red fluorescence differs depending on lesion activity, and the red fluorescence area and lesion volume change following remineralization. The results suggest that measuring red fluorescence may be a useful way of objectively evaluating lesion activity of smooth surface lesions.


Subject(s)
Dental Caries , Fluorescence , Humans , Light
4.
Transplant Proc ; 50(10): 3172-3180, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30503665

ABSTRACT

A hemodialysis (HD) catheter-related right atrial thrombus (RAT) is rarely encountered prior to kidney transplantation (KT) but necessitates a decision about whether to anticoagulate and/or delay the surgery. There is controversy surrounding the clinical implications of a RAT in this situation. It is sometimes considered fatal but other opinions consider it to be benign, especially when incidentally detected. We reviewed the clinical characteristics, management, and outcomes of a patient series with HD catheter-related RAT detected prior to KT and speculated on its clinical significance. Among 3677 cases of KT performed on 3607 patients between January 1997 and September 2015 in our single tertiary center, 11 cases of HD catheter-related RAT detected on transthoracic echocardiography (TTE) prior to KT were included for analysis. The average maximal diameter of the RAT was 23.2 ± 16.3 (SD in mm) and 9 (81.8%) of these 11 patients had no symptoms associated with the RAT. Four patients (36.3%) had their catheters replaced, 5 patients (45.5%) had their catheters removed, and the catheters were maintained in the remaining 2 patients (18.2%). Six patients (54.5%) were anticoagulated with either heparin or warfarin. However all 11 patients had a successful KT suggesting that a HD catheter-related RAT incidentally detected prior to this surgery may not be as serious as previously considered and should not be a reason for delaying the transplantation.


Subject(s)
Heart Diseases/etiology , Kidney Transplantation , Renal Dialysis/adverse effects , Thromboembolism/etiology , Adult , Catheters, Indwelling/adverse effects , Female , Humans , Incidental Findings , Male , Middle Aged , Retrospective Studies , Risk Factors , Seoul , Young Adult
5.
Int J Dent Hyg ; 16(2): 219-224, 2018 May.
Article in English | MEDLINE | ID: mdl-29532597

ABSTRACT

OBJECTIVE: The aim of this study was to analyse the enamel damage caused by ultrasonic scaling of teeth with various enamel conditions that are difficult to identify by visual inspection, such as enamel cracks, early caries and resin restorations. METHODS: In total, 120 tooth surfaces were divided into 4 experimental groups using a quantitative light-induced fluorescence-digital system: sound enamel group, enamel cracks group, early caries group and resin restoration group. A skilled dental hygienist performed ultrasonic scaling under a standardized set of conditions: a ≤ 15° angle between the scaler tip and tooth surface and 40-80 g of lateral pressure at the rate of 12 times/10 s. Following scaling, the depth of enamel damage was measured using a surface profilometer and observed using scanning electron microscopy (SEM). RESULTS: The damage depth was the greatest in the enamel cracks group (37.63 ± 34.42 µm), followed by the early caries group (26.81 ± 8.67 µm), resin restoration group (19.63 ± 6.73 µm) and the sound enamel group (17.00 ± 5.66 µm). The damage depth was significantly deeper in the enamel cracks and early caries groups than in the sound enamel group (P < .05). SEM clearly revealed enamel loss in the enamel cracks, early caries and resin restoration groups. CONCLUSIONS: The results of this study suggest that ultrasonic scaling can cause further damage to teeth with enamel cracks, early caries and resin restorations. Therefore, accurate identification of tooth conditions and calculus before the initiation of ultrasonic scaling is necessary to minimize damage.


Subject(s)
Dental Enamel/injuries , Dental Scaling/adverse effects , Ultrasonic Therapy/adverse effects , Dental Caries/complications , Dental Restoration, Permanent/adverse effects , Fluorescence , Humans , In Vitro Techniques , Microscopy, Electron, Scanning , Surface Properties
6.
Am J Transplant ; 17(11): 2955-2962, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28707821

ABSTRACT

Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management with anticoagulation. We wished to determine the prevalence of graft splenic vein (SV) thrombosis, as well as the clinical significance of non-occlusive thrombus observed on routine imaging. Records of 112 pancreas transplant recipients over a 5-year period at a single center were reviewed. Venous thrombosis was defined as absence of flow or presence of thrombus identified in any part of the graft SV on ultrasound. Thirty patients (27%) had some degree of thrombus or absence of flow in the SV on postoperative ultrasound. There were 5 graft losses in this group. Four were due to venous thrombosis, and occurred within 20 days of transplant. All patients with non-occlusive partial SV thrombus but normal arterial signal on Doppler ultrasound were successfully treated with IV heparin followed by warfarin for 3-6 months, and remained insulin independent. Findings of arterial signal abnormalities, such as absence or reversal of diastolic flow within the graft, require urgent operative intervention since this finding can be associated with more extensive thrombus that may lead to graft loss.


Subject(s)
Graft Rejection/therapy , Pancreas Transplantation/adverse effects , Postoperative Complications/therapy , Splenic Vein/pathology , Venous Thrombosis/therapy , Adult , Conservative Treatment , Female , Follow-Up Studies , Graft Rejection/diagnostic imaging , Graft Rejection/etiology , Graft Survival , Humans , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Postoperative Complications/etiology , Prognosis , Retrospective Studies , Risk Factors , Splenic Vein/diagnostic imaging , Ultrasonography , Venous Thrombosis/diagnostic imaging , Venous Thrombosis/etiology
7.
Oncogene ; 36(42): 5910-5913, 2017 10 19.
Article in English | MEDLINE | ID: mdl-28650467

ABSTRACT

L-asparaginase is a critical chemotherapeutic agent for acute lymphoblastic leukemia (ALL). It hydrolyzes plasma asparagine into aspartate and NH3, causing asparagine deficit and inhibition of protein synthesis and eventually, leukemic cell death. However, patient relapse often occurs due to development of resistance. The molecular mechanism by which ALL cells acquire resistance to L-asparaginase is unknown. Therefore, we sought to identify genes that are involved in L-asparaginase resistance in primary leukemic cells. By unbiased genome-wide RNAi screening, we found that among 10 resistant ALL clones, six hits were for opioid receptor mu 1 (oprm1), two hits were for carbonic anhydrase 1 (ca1) and another two hits were for ubiquitin-conjugating enzyme E2C (ube2c). We also found that OPRM1 is expressed in all leukemic cells tested. Specific knockdown of OPRM1 confers L-asparaginase resistance, validating our genome-wide retroviral shRNA library screening data. Methadone, an agonist of OPRM1, enhances the sensitivity of parental leukemic cells, but not OPRM1-depleted cells, to L-asparaginase treatment, indicating that OPRM1 is required for the synergistic action of L-asparaginase and methadone, and that OPRM1 loss promotes leukemic cell survival likely through downregulation of the OPRM1-mediated apoptotic pathway. Consistent with this premise, patient leukemic cells with relatively high levels of OPRM1 are more sensitive to L-asparaginase treatment compared to OPRM1-depleted leukemic cells, further indicating that OPRM1 loss has a crucial role in L-asparaginase resistance in leukemic patients. Thus, our study demonstrates for the first time, a novel OPRM1-mediated mechanism for L-asparaginase resistance in ALL, and identifies OPRM1 as a functional biomarker for defining high-risk subpopulations and for the detection of evolving resistant clones. Oprm1 may also be utilized for effective treatment of L-asparaginase-resistant ALL.


Subject(s)
Asparaginase/pharmacology , Biomarkers, Tumor/genetics , Genetic Testing/methods , Genome, Human , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , RNA, Small Interfering/genetics , Receptors, Opioid, mu/genetics , Adolescent , Apoptosis/drug effects , Carbonic Anhydrases/chemistry , Carbonic Anhydrases/genetics , Cell Proliferation/drug effects , Gene Expression Regulation, Neoplastic , Humans , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Receptors, Opioid, mu/antagonists & inhibitors , Tumor Cells, Cultured , Ubiquitin-Conjugating Enzymes/antagonists & inhibitors , Ubiquitin-Conjugating Enzymes/genetics
8.
Am J Transplant ; 17(9): 2444-2450, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28489277

ABSTRACT

Islet transplantation offers a minimally invasive approach for ß cell replacement in diabetic patients with hypoglycemic unawareness. Attempts at insulin independence may require multiple islet reinfusions from distinct donors, increasing the risk of allogeneic sensitization. Currently, solid organ pancreas transplant is the only remaining surgical option following failed islet transplantation in the United States; however, the immunologic impact of repeated exposure to donor antigens on subsequent pancreas transplantation is unclear. We describe a case series of seven patients undergoing solid organ pancreas transplant following islet graft failure with long-term follow-up of pancreatic graft survival and renal function. Despite highly variable panel reactive antibody levels prior to pancreas transplant (mean 27 ± 35%), all seven patients achieved stable and durable insulin independence with a mean follow-up of 6.7 years. Mean hemoglobin A1c values improved significantly from postislet, prepancreas levels (mean 8.1 ± 1.5%) to postpancreas levels (mean 5.3 ± 0.1%; p = 0.0022). Three patients experienced acute rejection episodes that were successfully managed with thymoglobulin and methylprednisolone, and none of these preuremic type 1 diabetic recipients developed stage 4 or 5 chronic kidney disease postoperatively. These results support pancreas-after-islet transplantation with aggressive immunosuppression and protocol biopsies as a viable strategy to restore insulin independence after islet graft failure.


Subject(s)
Diabetes Mellitus, Type 1/surgery , Graft Rejection/prevention & control , Islets of Langerhans Transplantation , Pancreas Transplantation , Adult , Female , Follow-Up Studies , Graft Survival , Humans , Immunosuppressive Agents/therapeutic use , Insulin/blood , Male , Middle Aged , Prognosis , Risk Factors , Young Adult
9.
Int J Dent Hyg ; 15(2): 120-127, 2017 May.
Article in English | MEDLINE | ID: mdl-26376737

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the proportions of end-rounded bristles via observations of the end patterns of various children's toothbrushes with scanning electron microscopy (SEM) and stereomicroscopy. METHODS: Ten different brands of children's toothbrushes were chosen, and tufts from each toothbrush were used. The prepared bristle specimens were observed on SEM and stereomicroscopic images and classified as acceptable (A1-A3) and non-acceptable (N1-N5) according to the modified classification. Then, the proportions of end-rounded bristles were calculated. RESULTS: Analyses of the 10 toothbrushes revealed that the proportions of acceptable end-rounded bristles ranged from 1.4% to 20.2% on SEM and from 0.0% to 18.0% on stereomicroscopic examinations. Additionally, some toothbrushes had labels that indicated bristle end-rounding, but the proportions of end-rounded bristles were low. CONCLUSIONS: The types and percentages of bristle ends of children's toothbrushes marketed in Korea were various, but the amount of acceptable end-rounded bristles was low. The result, that even toothbrushes labelled as end-rounded had potential to harm oral tissue, demonstrates that quality control for rounding bristle ends as well as the labelling for end-rounded bristles is needed.


Subject(s)
Equipment Design , Microscopy, Electron, Scanning , Microscopy , Toothbrushing/instrumentation , Child , Female , Humans , Male , Republic of Korea
10.
Cell Death Dis ; 6: e1844, 2015 Aug 06.
Article in English | MEDLINE | ID: mdl-26247729

ABSTRACT

In the central nervous system (CNS), hyperglycemia leads to neuronal damage and cognitive decline. Recent research has focused on revealing alterations in the brain in hyperglycemia and finding therapeutic solutions for alleviating the hyperglycemia-induced cognitive dysfunction. Adiponectin is a protein hormone with a major regulatory role in diabetes and obesity; however, its role in the CNS has not been studied yet. Although the presence of adiponectin receptors has been reported in the CNS, adiponectin receptor-mediated signaling in the CNS has not been investigated. In the present study, we investigated adiponectin receptor (AdipoR)-mediated signaling in vivo using a high-fat diet and in vitro using neural stem cells (NSCs). We showed that AdipoR1 protects cell damage and synaptic dysfunction in the mouse brain in hyperglycemia. At high glucose concentrations in vitro, AdipoR1 regulated the survival of NSCs through the p53/p21 pathway and the proliferation- and differentiation-related factors of NSCs via tailless (TLX). Hence, we suggest that further investigations are necessary to understand the cerebral AdipoR1-mediated signaling in hyperglycemic conditions, because the modulation of AdipoR1 might alleviate hyperglycemia-induced neuropathogenesis.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p21/genetics , Glucose/toxicity , Hyperglycemia/genetics , Receptors, Adiponectin/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Tumor Suppressor Protein p53/genetics , Animals , Cell Differentiation , Cell Proliferation , Cell Survival , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Diet, High-Fat/adverse effects , Gene Expression Regulation , Humans , Hyperglycemia/etiology , Hyperglycemia/metabolism , Hyperglycemia/pathology , Male , Mice , Mice, Inbred C57BL , Neural Stem Cells , Neurogenesis/drug effects , Neurogenesis/genetics , Primary Cell Culture , Receptors, Adiponectin/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Signal Transduction , Synapses/drug effects , Synapses/metabolism , Synapses/pathology , Tumor Suppressor Protein p53/metabolism
11.
Neuroscience ; 301: 26-38, 2015 Aug 20.
Article in English | MEDLINE | ID: mdl-26047734

ABSTRACT

In the central nervous system (CNS), insulin resistance (I/R) can cause defective neurite outgrowth and neuronal cell death, which can eventually lead to cognitive deficits. Recent research has focused on the relationship between I/R and the cognitive impairment caused by dementia, with the goal of developing treatments for dementia. Insulin signal transduction mediated by insulin receptor substrate (IRS-1) has been thoroughly studied in the CNS of patients with I/R. In the present study, we investigated whether the impairment of IRS-1-mediated insulin signaling contributes to neurite outgrowth and neuronal loss, both in mice fed a high-fat diet and in mouse neuroblastoma (Neuro2A) cells. To investigate the changes caused by the inhibition of IRS-1-mediated insulin signaling in the brain, we performed Cresyl Violet staining and immunochemical analysis. To investigate the changes caused by the inhibition of IRS-1-mediated insulin signaling in neuroblastoma cells, we performed Western blot analysis, reverse transcription-PCR, and immunochemical analysis. We show that the deactivation of IRS-1-mediated insulin signaling can inhibit neuronal outgrowth and aggravate neuronal cell death in the insulin-resistant CNS. Thus, IRS-1-mediated insulin signal transduction may be an important factor in the treatment of cognitive decline induced by I/R.


Subject(s)
Apoptosis , Brain/metabolism , Insulin Receptor Substrate Proteins/metabolism , Insulin Resistance , Neurons/metabolism , Animals , Brain/pathology , Cell Line, Tumor , Diet, High-Fat , Forkhead Box Protein O3 , Forkhead Transcription Factors/metabolism , Male , Mice , Mice, Inbred ICR , Neurites/metabolism , Neurons/pathology , Oncogene Protein v-akt/metabolism , Phosphorylation , Reactive Oxygen Species , Signal Transduction
12.
Osteoporos Int ; 26(8): 2121-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25963233

ABSTRACT

UNLABELLED: Heart failure is associated with increased risk of osteoporosis. We evaluated the prevalence and predictors of osteoporosis in hospitalized patients with ADHF using quantitative computed tomography. Osteoporosis and vertebral fracture are prevalent in patients with ADHF and exercise capacity independently predicts bone mass and femoral bone geometry. INTRODUCTION: Heart failure is associated with reduced bone mass and increased risk of osteoporotic fractures. However, the prevalence and predictors of osteoporosis in hospitalized patients with acute decompensated heart failure (ADHF) are not well understood. METHODS: Sixty-five patients (15 postmenopausal females and 50 males) with ADHF were prospectively and consecutively enrolled. After stabilization of heart failure symptoms, quantitative computed tomography for bone mineral density (BMD) and femoral geometry as well as biochemical, echocardiographic, and cardiopulmonary exercise tests were performed. RESULTS: Fifteen postmenopausal female showed a high prevalence of osteoporosis (40%) and vertebral fracture (53%). Among 50 male patients, 12% had osteoporosis and 32% had osteopenia, while vertebral fracture was found in 12%. Lumbar volumetric BMD (vBMD) was significantly lower in ischemic patients than non-ischemic patients (107.9 ± 47.5 vs. 145.4 ± 40.9 mg/cm(3), p = 0.005) in male. Exercise capacity, indicated by peak oxygen consumption (VO2), was significantly associated with lumbar vBMD (r = 0.576, p < 0.001) and total hip areal BMD (aBMD) (r = 0.512, p = 0.001) and cortical thickness of the femur neck (r = 0.544, p = 0.001). When controlled for age, body mass index, N-terminal proBrain natriuretic protein (NT-proBNP), etiology of heart failure, hemoglobin, and thigh circumference, multivariate regression analysis revealed peak VO2 independently predicted lumbar vBMD (ß = 0.448, p = 0.031), total hip aBMD (ß = 0.547, p = 0.021), and cortical thickness of the femur neck (ß = 0.590, p = 0.011). CONCLUSION: In male patients with ADHF, osteoporosis and vertebral fracture are prevalent, and exercise capacity independently predicts bone mass and geometry. Given that heart failure patients with reduced exercise capacity carry a substantial increased risk of fracture, proper osteoporosis evaluation is important in these patients.


Subject(s)
Bone Density/physiology , Exercise/physiology , Femur/pathology , Heart Failure/complications , Osteoporosis/etiology , Aged , Aged, 80 and over , Anthropometry/methods , Exercise Test/methods , Female , Femur Neck/physiopathology , Heart Failure/epidemiology , Heart Failure/pathology , Heart Failure/physiopathology , Humans , Lumbar Vertebrae/physiopathology , Male , Middle Aged , Osteoporosis/epidemiology , Osteoporosis/pathology , Osteoporosis/physiopathology , Osteoporotic Fractures/epidemiology , Osteoporotic Fractures/etiology , Osteoporotic Fractures/pathology , Osteoporotic Fractures/physiopathology , Prevalence , Prospective Studies , Republic of Korea/epidemiology , Tomography, X-Ray Computed
13.
Plant Biol (Stuttg) ; 17(5): 1013-22, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25940948

ABSTRACT

This study aimed to elucidate the role played by Enterobacter asburiae KE17 in the growth and metabolism of soybeans during copper (100 µm Cu) and zinc (100 µm Zn) toxicity. When compared to controls, plants grown under Cu and Zn stress exhibited significantly lower growth rates, but inoculation with E. asburiae KE17 increased growth rates of stressed plants. The concentrations of plant hormones (abscisic acid and salicylic acid) and rates of lipid peroxidation were higher in plants under heavy metal stress, while total chlorophyll, carotenoid content and total polyphenol concentration were lower. While the bacterial treatment reduced the abscisic acid and salicylic acid content and lipid peroxidation rate of Cu-stressed plants, it also increased the concentration of photosynthetic pigments and total polyphenol. Moreover, the heavy metals induced increased accumulation of free amino acids such as aspartic acid, threonine, serine, glycine, alanine, leucine, isoleucine, tyrosine, proline and gamma-aminobutyric acid, while E. asburiae KE17 significantly reduced concentrations of free amino acids in metal-affected plants. Co-treatment with E. asburiae KE17 regulated nutrient uptake by enhancing nitrogen content and inhibiting Cu and Zn accumulation in soybean plants. The results of this study suggest that E. asburiae KE17 mitigates the effects of Cu and Zn stress by reprogramming plant metabolic processes.


Subject(s)
Copper/toxicity , Enterobacter/physiology , Glycine max/microbiology , Plant Growth Regulators/metabolism , Zinc/toxicity , Abscisic Acid/metabolism , Amino Acids/metabolism , Base Sequence , Carotenoids/metabolism , Chlorophyll/metabolism , Enterobacter/genetics , Lipid Peroxidation/drug effects , Molecular Sequence Data , Phylogeny , Polyphenols/metabolism , Salicylic Acid/metabolism , Sequence Analysis, DNA , Glycine max/drug effects , Glycine max/physiology , Stress, Physiological
14.
Am J Transplant ; 15(3): 833-40, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25639881

ABSTRACT

Scedosporium spp. is the most common mold infection in pneumonia resulting from near-drowning. Three fatal scedosporiosis cases developed after solid organ transplantation, probably transmitted from the nearly-drowned donor. One heart transplant recipient and two kidney transplant recipients developed fatal scedosporiosis following deceased donor transplantation from the same donor, a nearly-drowned victim of a suicide attempt. Genotypically, indistinguishable strains of Scedosporium auratiacum were recovered from the three recipients. Two liver transplant recipients from the same donor received prophylactic voriconazole without any subsequent signs of infection. To determine the safety of donation from nearly-drowned donors, a national traceback investigation was also performed of the causes of deaths in all transplant recipients who received organs from drowned donors between 2001 and 2013. Over 13 years, 2600 deceased donor transplants were performed in Korea. Among these 2600 deceased donor transplants, 27 (1%) victims of drowning donated their organs. From these 27 donors, 84 patients received organ transplants and 18 died, including the above three. We found no microbiologic evidence of invasive mold transmission from the nearly-drowned donors to the other 15 recipients. Although disseminated infection in the donor could not be demonstrated by culture, undiagnosed disseminated donor infection and transmission of Scedosporium spp. should be considered in near-drowning events.


Subject(s)
Drowning , Mycoses/complications , Organ Transplantation , Pneumonia/complications , Adult , Child, Preschool , Female , Humans , Male , Middle Aged , Young Adult
15.
Cell Death Discov ; 1: 15011, 2015.
Article in English | MEDLINE | ID: mdl-27551446

ABSTRACT

Recently, γ-synuclein (SNCG), which is also known as breast cancer-specific gene-1, has been demonstrated to be an adverse and aggressive marker in breast cancer. In our previous study, SNCG was significantly upregulated in irradiated human breast cancer cells. The aim of this study was to investigate whether radiation-induced, tumor-derived SNCG can influence dendritic cell (DC) function in immune systems. The phenotypical and functional changes of DCs in the presence or absence of SNCG were investigated by FACS analysis, ELISA, and real-time PCR. The ability of SNCG-treated DCs to influence T cells was also examined by coculturing with T cells. The treatment of DCs with SNCG protein inhibited the surface expression of the co-stimulatory molecules CD40 and CD86, and decreased the mRNA levels of pro-inflammatory cytokines. The SNCG-treated DCs inhibited T-cell proliferation slightly, but distinctively increased the population of regulatory T cells. In addition, the production of TGF-ß from T cells was significantly increased when they were cocultured with SNCG-treated DCs. Taken together, these results demonstrate that tumor-derived SNCG contributes to immunosuppressive effects via the inhibition of DC differentiation and activation, thus making it a potential target for cancer treatment.

16.
Nutr Metab Cardiovasc Dis ; 24(11): 1240-5, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25096924

ABSTRACT

BACKGROUNDS AND AIMS: C-reactive protein (CRP) levels predict incident and recurrent cardiovascular disease (CVD) events; however, associations between CRP and pre-clinical atherosclerosis is less certain. Since high concentrations of high-density lipoprotein cholesterol (HDL-C) are inversely associated with CVD risk, we investigated whether HDL-C modified the association between CRP concentration and measures of preclinical atherosclerosis. METHODS AND RESULTS: Data were analyzed from a Korean occupational cohort of 12,030 male subjects who underwent a cardiac computed tomography (CT) estimation of coronary artery calcification (CAC) score and an assessment of CVD risk factors. Logistic regression was used to describe associations between CRP and measures of pre-clinical atherosclerosis, such as CAC scores >0. As many as 1351 (11.2%) participants had a CAC score>0. CRP was stratified into 3 groups based on clinical category: <1 mg/L, 1 to <2 mg/L, and ≥ 2 mg/dL. In the bottom CRP group, 907/8697 (10.4%) of subjects had a CAC score >0, compared with 242/1943 (12.5%) in the middle group and 202/1396 (14.5%) in the top CRP group (p < 0.0001). After adjustment for multiple CVD risk factors, there was a positive association between CRP and CAC score>0 (OR between top and bottom CRP groups, 1.41 [1.04, 1.90], p = 0.027) in the lowest HDL-C quartile but not in the highest HDL-C (OR between top and bottom CRP group, 0.80 [0.46, 1.39], p = 0.425). CONCLUSION: The association between CRP concentration and CAC score differed according to HDL-C levels.


Subject(s)
Atherosclerosis/blood , C-Reactive Protein/metabolism , Calcium/blood , Cholesterol, HDL/blood , Coronary Artery Disease/blood , Adult , Aged , Atherosclerosis/diagnosis , Cholesterol, LDL/blood , Cohort Studies , Coronary Artery Disease/diagnosis , Cross-Sectional Studies , Healthy Volunteers , Humans , Logistic Models , Male , Middle Aged , Republic of Korea , Surveys and Questionnaires , Triglycerides/blood
17.
Transplant Proc ; 46(6): 2002-6, 2014.
Article in English | MEDLINE | ID: mdl-25131094

ABSTRACT

BACKGROUND: A recent study by Chen et al described a therapy for diabetes that involved electroporation of primary hepatocytes with human proinsulin cDNA, p3MTChins. Intrahepatic transplantation of treated hepatocytes into streptozotocin (STZ) murine and porcine models led to euglycemia, weight maintenance, and normal insulin production. We tested the repeatability of their basic experiments and transplantation technique and expanded the study to include an autoimmune model. METHODS: Hepatocytes were isolated from B6 mice, electroporated with p3MTChins, and glucose-challenged or were injected into hepatic or spleen parenchyma of STZ-diabetic B6 and non-obese diabetic mice. Outcomes included survival, serum glucose levels, insulin, and c-peptide release. Untransfected primary hepatocytes and mice transplanted with these cells served as controls. RESULTS: p3MTChins-hepatocytes secreted insulin during glucose challenge, but glucose levels did not change with increasing glucose concentrations. Direct hepatic injection led to high mortality rates. Mice that underwent intrasplenic injection survived for >50 days (control = 4 days) and had a mild but stable improvement in hyperglycemia. C-peptide in both mouse models was detectable but eventually declined to baseline in the non-obese diabetic mice. CONCLUSIONS: Hepatocytes can be transfected with p3MTChins to produce human insulin but may lack the proper glucose-sensing or complex storage and secretion capabilities that allow for a finely tuned dynamic insulin response. Treatment is subtherapeutic, and p3MTChins-hepatocyte function may not endure in an autoimmune model. Without successful preliminary findings, cell therapy involving electroporation of p3MTChins does not appear to be practical as a therapy for diabetes and may not be a strategy to pursue at this time.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/therapy , Genetic Therapy , Hepatocytes/transplantation , Proinsulin/genetics , Animals , Blood Glucose/metabolism , C-Peptide/metabolism , DNA, Complementary/genetics , Diabetes Mellitus, Experimental/etiology , Electroporation , Gene Transfer Techniques , Humans , Insulin/metabolism , Liver , Male , Mice , Mice, Inbred NOD , Spleen , Streptozocin , Swine
18.
Int J Oral Maxillofac Surg ; 43(7): 816-23, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24685262

ABSTRACT

The aim of this study was to investigate the effect of porous polyethylene (PPE) in paranasal augmentation on midfacial soft tissue architecture. This retrospective study recruited patients with midface retrusion and mandibular prognathism. Twenty adult patients who had undergone bilateral PPE augmentation (ready-made type, thickness 4.5mm, Medpor) to the piriform aperture and simultaneous mandibular setback surgery were included in this study. The soft tissue morphology and thickness of the midface were evaluated using three-dimensional reformatted images from cone beam computed tomography done before and 6 months after surgery. The soft tissue outline of the midface was augmented 1-4mm. The average increase in soft tissue outline near the peri-alar region was 3.1-3.4mm, which comprised 68-74% of the PPE thickness (P<0.01). The nasolabial angle and columellar inclination were increased significantly (2.2° and 1.4°, respectively; both P<0.05), whereas the nasal tip angle, nasal tip protrusion, columellar length, and bilateral nostril axis angle did not change. The alar base became wider on average by 2.2mm (P<0.01). The results showed that paranasal augmentation with PPE significantly increased the overlying soft tissue outline without influencing the nasal projection and could enhance paranasal aesthetics with minimal morbidity.


Subject(s)
Malocclusion, Angle Class III/surgery , Polyethylene/chemistry , Prognathism/surgery , Prostheses and Implants , Rhinoplasty/methods , Adolescent , Adult , Biocompatible Materials , Bone Screws , Cone-Beam Computed Tomography , Female , Humans , Imaging, Three-Dimensional , Male , Malocclusion, Angle Class III/diagnostic imaging , Osteotomy, Sagittal Split Ramus , Porosity , Prognathism/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted , Retrospective Studies , Treatment Outcome
19.
Am J Transplant ; 14(1): 27-38, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24354870

ABSTRACT

Regulatory T cells (Tregs) are essential for the establishment and maintenance of immune tolerance, suggesting a potential therapeutic role for Tregs in transplantation. However, Treg administration alone is insufficient in inducing long-term allograft survival in normal hosts, likely due to the high frequency of alloreactive T cells. We hypothesized that a targeted reduction of alloreactive T effector cells would allow a therapeutic window for Treg efficacy. Here we show that preconditioning recipient mice with donor-specific transfusion followed by cyclophosphamide treatment deleted 70-80% donor-reactive T cells, but failed to prolong islet allograft survival. However, infusion of either 5 × 10(6) Tregs with direct donor reactivity or 25 × 10(6) polyclonal Tregs led to indefinite survival of BALB/c islets in more than 70% of preconditioned C57BL/6 recipients. Notably, protection of C3H islets in autoimmune nonobese diabetic mice required islet autoantigen-specific Tregs together with polyclonal Tregs. Treg therapy led to significant reduction of CD8(+) T cells and concomitant increase in endogenous Tregs among graft-infiltrating cells early after transplantation. Together, these results demonstrate that reduction of the donor-reactive T cells will be an important component of Treg-based therapies in transplantation.


Subject(s)
Islets of Langerhans Transplantation/immunology , T-Lymphocytes, Regulatory/transplantation , Allografts/immunology , Animals , CD8-Positive T-Lymphocytes/transplantation , Cyclophosphamide/therapeutic use , Graft Survival , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred NOD , Tissue Donors , Transplantation Conditioning/methods
20.
J Oral Rehabil ; 40(12): 916-22, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24237358

ABSTRACT

This study examined changes in masticatory function after botulinum toxin type A (BTX-A) injection using objective and subjective tests during 12 weeks. Also, we compared differences in masticatory function between group in which only masseter muscle (M group) was injected and group in which masseter and temporal muscle (M-T group) were injected. Forty subjects were assigned into two groups; M group (n = 20) and the M-T group (n = 20). The Meditoxin(®) was used as BTX-A injection. The mixing ability index (MAI) was used as the objective indicator, and visual analogue scale (VAS) and food intake ability (FIA) index were used as subjective indicators. Overall, the masticatory function drastically declined after 4 weeks and gradually recovered with time. Compared with the pre-injection state, the masticatory function decreased by 89·2% (MAI), 12·2% (FIA) and 32·2% (VAS) 4 weeks after the injection (P < 0·05). When the results between M group and M-T group were compared, scores of VAS and FIA were significantly different 4 weeks after the injection (P < 0·05), but the MAI score showed no significant difference between two groups. In conclusion, this study showed that masticatory function was significantly decreased after BTX-A injection into the masticatory muscle after 4 and 8 weeks from injection. However, masticatory efficiency measured using MAI could completely recover after 12 weeks. Furthermore, after 8 weeks from the injection, the masticatory function measured after injection into only the masseter muscle was similar to that measured after injection into both masseter and temporal muscle.


Subject(s)
Botulinum Toxins, Type A/administration & dosage , Masseter Muscle/physiopathology , Mastication/physiology , Muscle Weakness/chemically induced , Neuromuscular Agents/administration & dosage , Temporal Muscle/physiopathology , Adult , Bite Force , Botulinum Toxins, Type A/pharmacology , Female , Humans , Injections, Intramuscular , Male , Masseter Muscle/drug effects , Mastication/drug effects , Neuromuscular Agents/pharmacology , Pain Measurement , Recovery of Function , Temporal Muscle/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...